Breast Cancer–Specific mRNA Transcripts Presence in Peripheral Blood After Adjuvant Chemotherapy Predicts Poor Survival Among High-Risk Breast Cancer Patients Treated With High-Dose Chemotherapy With Peripheral Blood Stem Cell Support
Miguel Quintela-Fandiño(Spanish National Cancer Research Centre), H. Cortés-Funes(Centre Hospitalier René-Dubos), Javier Hornedo(Marqués de Valdecilla University Hospital), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Soledad Gamarra(Research Institute Hospital 12 de Octubre), Florinda Gilsanz(Hospital Universitario HM Madrid), Rosa Ayala(Hospital Universitario 12 De Octubre), Ricardo Hitt(Hospital Universitario Severo Ochoa), Cecilia Guzmán(Roche (Spain)), Antonio Jimeno(University of Colorado Cancer Center)
Cited by 37
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
|New England Journal of Medicine|2008|3.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k